Black Diamond Financial LLC Sells 55 Shares of Danaher Co. (NYSE:DHR)

Black Diamond Financial LLC decreased its holdings in Danaher Co. (NYSE:DHR) by 5.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 917 shares of the conglomerate’s stock after selling 55 shares during the period. Black Diamond Financial LLC’s holdings in Danaher were worth $211,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of DHR. AMF Tjanstepension AB bought a new stake in shares of Danaher in the third quarter worth $5,923,000. Howard Capital Management Group LLC grew its holdings in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares during the period. Dakota Wealth Management grew its holdings in shares of Danaher by 1.0% in the third quarter. Dakota Wealth Management now owns 8,161 shares of the conglomerate’s stock worth $2,269,000 after acquiring an additional 82 shares during the period. Allworth Financial LP grew its holdings in shares of Danaher by 6.1% in the third quarter. Allworth Financial LP now owns 5,337 shares of the conglomerate’s stock worth $1,484,000 after acquiring an additional 307 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Danaher by 3.8% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 79,222 shares of the conglomerate’s stock worth $21,821,000 after acquiring an additional 2,879 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $209.86 on Monday. The stock’s 50-day simple moving average is $226.71 and its 200-day simple moving average is $246.84. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The company has a market capitalization of $151.58 billion, a price-to-earnings ratio of 39.75, a PEG ratio of 2.66 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 EPS. As a group, analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. Danaher’s payout ratio is currently 20.45%.

Analyst Upgrades and Downgrades

DHR has been the subject of several research analyst reports. The Goldman Sachs Group set a $250.00 price objective on Danaher in a report on Wednesday, January 15th. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 price objective (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Scotiabank started coverage on Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target for the company. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.